4mot - Revision history

OCA at 12:28, 1 March 2024

OCA — Fri, 01 Mar 2024 12:28:00 GMT

←Older revision		Revision as of 12:28, 1 March 2024
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4mot]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Streptococcus_pneumoniae_R6 Streptococcus pneumoniae R6]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4MOT OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4MOT FirstGlance]. <br>		<table><tr><td colspan='2'>[[4mot]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Streptococcus_pneumoniae_R6 Streptococcus pneumoniae R6]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4MOT OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4MOT FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=2B7:1-[4-(3-METHYLBUTYL)-5-OXO-6-(PYRIDIN-3-YL)-4,5-DIHYDRO[1,3]THIAZOLO[5,4-B]PYRIDIN-2-YL]-3-PROP-2-EN-1-YLUREA'>2B7</scene></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.75Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=2B7:1-[4-(3-METHYLBUTYL)-5-OXO-6-(PYRIDIN-3-YL)-4,5-DIHYDRO[1,3]THIAZOLO[5,4-B]PYRIDIN-2-YL]-3-PROP-2-EN-1-YLUREA'>2B7</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4mot FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4mot OCA], [https://pdbe.org/4mot PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4mot RCSB], [https://www.ebi.ac.uk/pdbsum/4mot PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4mot ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4mot FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4mot OCA], [https://pdbe.org/4mot PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4mot RCSB], [https://www.ebi.ac.uk/pdbsum/4mot PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4mot ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
	[https://www.uniprot.org/uniprot/Q8DQB5_STRR6 Q8DQB5_STRR6]		[https://www.uniprot.org/uniprot/Q8DQB5_STRR6 Q8DQB5_STRR6]
-	<div style="background-color:#fffaf0;">
-	== Publication Abstract from PubMed ==
-	Scaffold hopping from the thiazolopyridine ureas led to thiazolopyridone ureas with potent antitubercular activity acting through inhibition of DNA GyrB ATPase activity. Structural diversity was introduced, by extension of substituents from the thiazolopyridone N-4 position, to access hydrophobic interactions in the ribose pocket of the ATP binding region of GyrB. Further optimization of hydrogen bond interactions with arginines in site-2 of GyrB active site pocket led to potent inhibition of the enzyme (IC50 2nM) along with potent cellular activity (MIC=0.1muM) against Mycobacterium tuberculosis (Mtb). Efficacy was demonstrated in an acute mouse model of tuberculosis on oral administration.
-
-	Thiazolopyridone ureas as DNA gyrase B inhibitors: Optimization of antitubercular activity and efficacy.,Kale RR, Kale MG, Waterson D, Raichurkar A, Hameed SP, Manjunatha MR, Kishore Reddy BK, Malolanarasimhan K, Shinde V, Koushik K, Jena LK, Menasinakai S, Humnabadkar V, Madhavapeddi P, Basavarajappa H, Sharma S, Nandishaiah R, Mahesh Kumar KN, Ganguly S, Ahuja V, Gaonkar S, Naveen Kumar CN, Ogg D, Boriack-Sjodin PA, Sambandamurthy VK, de Sousa SM, Ghorpade SR Bioorg Med Chem Lett. 2014 Feb 1;24(3):870-9. doi: 10.1016/j.bmcl.2013.12.080., Epub 2013 Dec 25. PMID:24405701<ref>PMID:24405701</ref>
-
-	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	</div>
-	<div class="pdbe-citations 4mot" style="background-color:#fffaf0;"></div>

	==See Also==		==See Also==
	*[[Topoisomerase 3D structures\|Topoisomerase 3D structures]]		*[[Topoisomerase 3D structures\|Topoisomerase 3D structures]]
-	== References ==
-	<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>

OCA at 09:58, 28 December 2022

OCA — Wed, 28 Dec 2022 09:58:44 GMT

←Older revision		Revision as of 09:58, 28 December 2022
Line 1:		Line 1:

	==Structure of Streptococcus pneumonia pare in complex with AZ13072886==		==Structure of Streptococcus pneumonia pare in complex with AZ13072886==
-	<StructureSection load='4mot' size='340' side='right' caption='[[4mot]], [[Resolution\|resolution]] 1.75Å' scene=''>	+	<StructureSection load='4mot' size='340' side='right'caption='[[4mot]], [[Resolution\|resolution]] 1.75Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4mot]] is a 1 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Strr6 Strr6~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4MOT OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4MOT FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4mot]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Streptococcus_pneumoniae_R6 Streptococcus pneumoniae R6]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4MOT OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4MOT FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=2B7:1-[4-(3-METHYLBUTYL)-5-OXO-6-(PYRIDIN-3-YL)-4,5-DIHYDRO[1,3]THIAZOLO[5,4-B]PYRIDIN-2-YL]-3-PROP-2-EN-1-YLUREA'>2B7</scene>~~</td></tr>~~	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=2B7:1-[4-(3-METHYLBUTYL)-5-OXO-6-(PYRIDIN-3-YL)-4,5-DIHYDRO[1,3]THIAZOLO[5,4-B]PYRIDIN-2-YL]-3-PROP-2-EN-1-YLUREA'>2B7</scene></td></tr>
-	~~<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4em7\|4em7]], [[4emv\|4emv]], [[4mbc\|4mbc]], [[4mb9\|4mb9]]</td></tr>~~	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4mot FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4mot OCA], [https://pdbe.org/4mot PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4mot RCSB], [https://www.ebi.ac.uk/pdbsum/4mot PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4mot ProSAT]</span></td></tr>
-	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">parE, spar94_0831, spr0756 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=171101 STRR6])</td></tr>	+
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4mot FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4mot OCA], [~~http~~://pdbe.org/4mot PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4mot RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4mot PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4mot ProSAT]</span></td></tr>	+
	</table>		</table>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/Q8DQB5_STRR6 Q8DQB5_STRR6]
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 18:		Line 18:
	</div>		</div>
	<div class="pdbe-citations 4mot" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 4mot" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Topoisomerase 3D structures\|Topoisomerase 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Strr6~~]]	+	[[Category: Large Structures]]
-	[[Category: ~~Boriack-Sjodin, P A~~]]	+	[[Category: Streptococcus pneumoniae R6]]
-	[[Category: ~~Ogg, D]]~~	+	[[Category: Boriack-Sjodin PA]]
-	~~[[Category: Antimicrobial]]~~	+	[[Category: Ogg D]]
-	~~[[Category: Atp binding]]~~	+
-	~~[[Category: Isomerase~~-~~isomerase inhibitor complex~~]]	+
-	[[Category: ~~Structure-based drug design]]~~	+
-	~~[[Category: Virtual screen~~]]	+

OCA at 20:11, 24 January 2018

OCA — Wed, 24 Jan 2018 20:11:46 GMT

←Older revision		Revision as of 20:11, 24 January 2018
Line 18:		Line 18:
	</div>		</div>
	<div class="pdbe-citations 4mot" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 4mot" style="background-color:#fffaf0;"></div>
-
-	==See Also==
-	*[[Topoisomerase\|Topoisomerase]]
	== References ==		== References ==
	<references/>		<references/>

OCA at 07:11, 23 December 2016

OCA — Fri, 23 Dec 2016 07:11:14 GMT

←Older revision		Revision as of 07:11, 23 December 2016
Line 1:		Line 1:
		+
	==Structure of Streptococcus pneumonia pare in complex with AZ13072886==		==Structure of Streptococcus pneumonia pare in complex with AZ13072886==
	<StructureSection load='4mot' size='340' side='right' caption='[[4mot]], [[Resolution\|resolution]] 1.75Å' scene=''>		<StructureSection load='4mot' size='340' side='right' caption='[[4mot]], [[Resolution\|resolution]] 1.75Å' scene=''>
Line 6:		Line 7:
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4em7\|4em7]], [[4emv\|4emv]], [[4mbc\|4mbc]], [[4mb9\|4mb9]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4em7\|4em7]], [[4emv\|4emv]], [[4mbc\|4mbc]], [[4mb9\|4mb9]]</td></tr>
	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">parE, spar94_0831, spr0756 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=171101 STRR6])</td></tr>		<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">parE, spar94_0831, spr0756 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=171101 STRR6])</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4mot FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4mot OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4mot RCSB], [http://www.ebi.ac.uk/pdbsum/4mot PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4mot FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4mot OCA], [http://pdbe.org/4mot PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4mot RCSB], [http://www.ebi.ac.uk/pdbsum/4mot PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4mot ProSAT]</span></td></tr>
	</table>		</table>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
Line 16:		Line 17:
	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	</div>		</div>
		+	<div class="pdbe-citations 4mot" style="background-color:#fffaf0;"></div>

	==See Also==		==See Also==

OCA at 08:16, 15 February 2015

OCA — Sun, 15 Feb 2015 08:16:04 GMT

←Older revision		Revision as of 08:16, 15 February 2015
Line 1:		Line 1:
-	~~{{STRUCTURE_4mot\| PDB=4mot \| SCENE= }}~~	+	==Structure of Streptococcus pneumonia pare in complex with AZ13072886==
-	===Structure of Streptococcus pneumonia pare in complex with AZ13072886===	+	<StructureSection load='4mot' size='340' side='right' caption='[[4mot]], [[Resolution\|resolution]] 1.75Å' scene=''>
-	~~{{ABSTRACT_PUBMED_24405701}}~~	+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[4mot]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Strr6 Strr6]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4MOT OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4MOT FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=2B7:1-[4-(3-METHYLBUTYL)-5-OXO-6-(PYRIDIN-3-YL)-4,5-DIHYDRO[1,3]THIAZOLO[5,4-B]PYRIDIN-2-YL]-3-PROP-2-EN-1-YLUREA'>2B7</scene></td></tr>
		+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4em7\|4em7]], [[4emv\|4emv]], [[4mbc\|4mbc]], [[4mb9\|4mb9]]</td></tr>
		+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">parE, spar94_0831, spr0756 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=171101 STRR6])</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4mot FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4mot OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4mot RCSB], [http://www.ebi.ac.uk/pdbsum/4mot PDBsum]</span></td></tr>
		+	</table>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Scaffold hopping from the thiazolopyridine ureas led to thiazolopyridone ureas with potent antitubercular activity acting through inhibition of DNA GyrB ATPase activity. Structural diversity was introduced, by extension of substituents from the thiazolopyridone N-4 position, to access hydrophobic interactions in the ribose pocket of the ATP binding region of GyrB. Further optimization of hydrogen bond interactions with arginines in site-2 of GyrB active site pocket led to potent inhibition of the enzyme (IC50 2nM) along with potent cellular activity (MIC=0.1muM) against Mycobacterium tuberculosis (Mtb). Efficacy was demonstrated in an acute mouse model of tuberculosis on oral administration.

-	~~==About this Structure==~~	+	Thiazolopyridone ureas as DNA gyrase B inhibitors: Optimization of antitubercular activity and efficacy.,Kale RR, Kale MG, Waterson D, Raichurkar A, Hameed SP, Manjunatha MR, Kishore Reddy BK, Malolanarasimhan K, Shinde V, Koushik K, Jena LK, Menasinakai S, Humnabadkar V, Madhavapeddi P, Basavarajappa H, Sharma S, Nandishaiah R, Mahesh Kumar KN, Ganguly S, Ahuja V, Gaonkar S, Naveen Kumar CN, Ogg D, Boriack-Sjodin PA, Sambandamurthy VK, de Sousa SM, Ghorpade SR Bioorg Med Chem Lett. 2014 Feb 1;24(3):870-9. doi: 10.1016/j.bmcl.2013.12.080., Epub 2013 Dec 25. PMID:24405701<ref>PMID:24405701</ref>
-	~~[[4mot]] is a 1 chain structure with sequence from [http~~:~~//en~~.~~wikipedia~~.~~org/wiki/Strr6 Strr6]~~. ~~Full crystallographic information is available from [http~~:/~~/oca~~.~~weizmann~~.ac.~~il/oca-bin/ocashort?id=4MOT OCA]~~.	+

-	==~~Reference~~==	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	~~<ref group~~=~~"xtra">PMID:024405701</ref>~~<references ~~group="xtra"~~/><~~references~~/>	+	</div>
		+
		+	==See Also==
		+	*[[Topoisomerase\|Topoisomerase]]
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
	[[Category: Strr6]]		[[Category: Strr6]]
	[[Category: Boriack-Sjodin, P A]]		[[Category: Boriack-Sjodin, P A]]
-	[[Category: Ogg, D.]]	+	[[Category: Ogg, D]]
	[[Category: Antimicrobial]]		[[Category: Antimicrobial]]
	[[Category: Atp binding]]		[[Category: Atp binding]]

OCA at 03:13, 13 February 2014

OCA — Thu, 13 Feb 2014 03:13:02 GMT

←Older revision		Revision as of 03:13, 13 February 2014
Line 1:		Line 1:
	{{STRUCTURE_4mot\| PDB=4mot \| SCENE= }}		{{STRUCTURE_4mot\| PDB=4mot \| SCENE= }}
	===Structure of Streptococcus pneumonia pare in complex with AZ13072886===		===Structure of Streptococcus pneumonia pare in complex with AZ13072886===
		+	{{ABSTRACT_PUBMED_24405701}}

	==About this Structure==		==About this Structure==
	[[4mot]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Strr6 Strr6]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4MOT OCA].		[[4mot]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Strr6 Strr6]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4MOT OCA].
		+
		+	==Reference==
		+	<ref group="xtra">PMID:024405701</ref><references group="xtra"/><references/>
	[[Category: Strr6]]		[[Category: Strr6]]
	[[Category: Boriack-Sjodin, P A]]		[[Category: Boriack-Sjodin, P A]]

OCA at 08:22, 27 November 2013

OCA — Wed, 27 Nov 2013 08:22:36 GMT

←Older revision		Revision as of 08:22, 27 November 2013
Line 3:		Line 3:

	==About this Structure==		==About this Structure==
-	[[4mot]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4MOT OCA].	+	[[4mot]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Strr6 Strr6]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4MOT OCA].
		+	[[Category: Strr6]]
	[[Category: Boriack-Sjodin, P A]]		[[Category: Boriack-Sjodin, P A]]
	[[Category: Ogg, D.]]		[[Category: Ogg, D.]]

OCA at 13:46, 20 November 2013

OCA — Wed, 20 Nov 2013 13:46:04 GMT

←Older revision		Revision as of 13:46, 20 November 2013
Line 1:		Line 1:
-	~~'''Unreleased structure'''~~	+	{{STRUCTURE_4mot\| PDB=4mot \| SCENE= }}
		+	===Structure of Streptococcus pneumonia pare in complex with AZ13072886===

-	~~The entry~~ 4mot is ~~ON HOLD~~	+	==About this Structure==
-		+	[[4mot]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4MOT OCA].
-	~~Authors~~: ~~Ogg, D~~., Boriack-Sjodin, P.A	+	[[Category: Boriack-Sjodin, P A]]
-		+	[[Category: Ogg, D.]]
-	~~Description~~: ~~Structure of Streptococcus pneumonia pare in~~ complex ~~with AZ13072886~~	+	[[Category: Antimicrobial]]
		+	[[Category: Atp binding]]
		+	[[Category: Isomerase-isomerase inhibitor complex]]
		+	[[Category: Structure-based drug design]]
		+	[[Category: Virtual screen]]

OCA at 07:39, 29 September 2013

OCA — Sun, 29 Sep 2013 07:39:41 GMT

←Older revision		Revision as of 07:39, 29 September 2013
Line 3:		Line 3:
	The entry 4mot is ON HOLD		The entry 4mot is ON HOLD

-	Authors: Ogg, ~~Derek~~, Boriack-Sjodin, P.A	+	Authors: Ogg, D., Boriack-Sjodin, P.A

-	Description: ~~STRUCTURE OF STREPTOCOCCUS PNEUMONIA PARE IN COMPLEX WITH~~ AZ13072886	+	Description: Structure of Streptococcus pneumonia pare in complex with AZ13072886

OCA: Protected "4mot" [edit=sysop:move=sysop]

OCA — Fri, 20 Sep 2013 03:45:07 GMT

Protected "4mot" [edit=sysop:move=sysop]

←Older revision

Revision as of 03:45, 20 September 2013